83.6k views
1 vote
Pts receiving doxorubicin. What test is appropriate for toxicity monitoring?

User Kalkin
by
8.7k points

1 Answer

0 votes

Final answer:

For toxicity monitoring in patients receiving rubicund, echo cardiograms or MUGS scans assessing cardiac function, as well as blood counts, and liver and kidney function tests are appropriate.

Step-by-step explanation:

For patients receiving rubicund, an appropriate test for monitoring toxicity is the assessment of cardiac function. This is crucial because rubicund can cause cardio toxicity. The monitoring includes performing echo cardiograms or multi gated acquisition (MUGS) scans to evaluate the left ventricular ejection fraction (LIEF), ensuring it remains within normal limits.

Additionally, monitoring blood counts is essential due to the risk of presupposition, while liver and kidney function tests are important to assess for potential hepatocyte and synchronicity, respectively. Periodic testing throughout treatment is recommended to detect any changes early and manage potential toxicities.

User Chebyr
by
8.3k points